AVITA Medical, Inc. (RCEL): Cost of Revenue

Annual figures by period end, from SEC filings.

$12.79M
Year ended 2025-12-31
$13.95M
Trailing 12 months to 2026-06-30
+28.4%
3-year compound annual growth
2018-06-30: $546.0K2019-06-30: $1.27M2020-06-30: $2.97M2021-06-30: $5.95M2022-12-31: $6.04M2023-12-31: $7.78M2024-12-31: $9.09M2025-12-31: $12.79M$12.79M
2018-06-30 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$12.79M+40.7%2026-02-12, From 2025-01-01
2024-12-31$9.09M+16.9%2026-02-12, From 2024-01-01
2023-12-31$7.78M+28.8%2025-02-13, From 2023-01-01
2022-12-31$6.04Mn/a2024-02-22, From 2022-01-01
No annual figure between 2021-06-30 and 2022-12-31.
2021-06-30$5.95M+100.1%2023-02-23, From 2020-07-01
2020-06-30$2.97M+133.9%2021-08-26, From 2019-07-01
2019-06-30$1.27M+132.8%2021-08-26, From 2018-07-01
2018-06-30$546.0Kn/a2020-08-27, From 2017-07-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
AVITA Medical, Inc. (RCEL)2025-12-31$12.79M+40.7%
Sight Sciences, Inc. (SGHT)2025-12-31$10.70M-7.6%
PRO DEX Inc (PDEX)2026-06-30$53.21M+13.0%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$42.63M-33.0%
Iradimed Corp (IRMD)2025-12-31$19.49M+15.4%
Delcath Systems, Inc. (DCTH)2025-12-31$11.80M+90.6%
LENSAR, Inc. (LNSR)2025-12-31$31.31M+13.3%
Pulmonx Corp (LUNG)2025-12-31$23.36M+7.2%
CVRx, Inc. (CVRX)2025-12-31$8.31M-0.3%

Compare RCEL, SGHT, PDEX, MHUAF side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗